Last Week’s Top-3 Most Read Posts On Pulmonary Fibrosis



1. Esbriet’s Promise and Potential as a PF Therapy

2. IPF Experts Discuss Disease Diagnosis and Treatment at CHEST 2015

3. Boehringer Ingelheim’s OFEV (Nintedanib) IPF Therapy Reinforces Efficacy and Safety Profile in New Studies


How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *